Idiopathic pulmonary fibrosis (IPF) occurs predominantly in middle-aged and older adults
and accounts for 20% to 30% of interstitial lung diseases. It is usually progressive, resulting …

Sarcoidosis is an uncommon systemic inflammatory disorder characterized by noncaseating
granulomatous inflammation that most commonly affects the lungs, intrathoracic lymph …

Background: This document updates the American Thoracic Society/European Respiratory
Society/Japanese Respiratory Society/Latin American Thoracic Association guideline on …

This document is an international evidence-based guideline on the diagnosis and
management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American …

Background Idiopathic pulmonary fibrosis (IPF) is a distinct form of interstitial pneumonia
with unknown origin and poor prognosis. Current pharmacologic treatments are limited and …

Background Lung transplantation is the final treatment option in the end stage of certain lung
diseases, once all possible conservative treatments have been exhausted. Depending on …

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with a prognosis
that can be worse than for many cancers. The initial stages of the condition were thought to …

Аннотация Представлены современные подходы к диагностике и терапии
идиопатического легочного фиброза (ИЛФ). Клинические рекомендации направлены …

Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease characterized by progressive
loss of lung function and poor prognosis. The so-called acute exacerbation of IPF (AE-IPF) …

Depression carries enormous global morbidity and is 1.5–7 times likelier to occur in
individuals with chronic illness than in the general population. Idiopathic pulmonary fibrosis …